Oxford Asset Management’s ARTHROCARE CORP ARTC Stock Holding History

Oxford Asset Management’s Portfolio ARTC Stock Details ARTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-45,250	Closed	-$1.82M	–	887
2013 Q4	$1.82M	Sell	45,250 -70,602	-61%	-$2.62M	0.05%	434
2013 Q3	$4.12M	Buy	115,852 +42,384	+58%	+$1.48M	0.09%	290
2013 Q2	$2.54M	Buy	+73,468	New	+$2.53M	0.07%	413

Other funds holding ARTC

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Oxford Asset Management's ARTC Position: Q1 2014 in Review

Oxford Asset Management sold out of ARTHROCARE CORP (ARTC) in Q1 2014, closing a stake of 45,250 shares — an estimated $1.82M sold.

Oxford Asset Management first reported a position in ARTC in Q2 2013 and held it in 3 quarters. The position peaked at $4.12M in Q3 2013. 117 funds tracked by Wall St. Rank hold ARTC as of Q1 2014.

Oxford Asset Management reported no remaining ARTHROCARE CORP position as of Q1 2014 after selling out during the quarter.
Oxford Asset Management sold 45,250 ARTHROCARE CORP shares in Q1 2014, an estimated $1.82M.
Oxford Asset Management first reported a position in ARTHROCARE CORP in Q2 2013 and held it in 3 quarters.
Oxford Asset Management's ARTHROCARE CORP position peaked at $4.12M in Q3 2013.
117 funds tracked by Wall St. Rank held ARTHROCARE CORP as of Q1 2014.

Based on Oxford Asset Management's 13F filing for Q1 2014, filed 5 May 2014.